A citation-based method for searching scientific literature

Alexis Forterre, Hiroaki Komuro, Shakhlo Aminova, Masako Harada. Cancers (Basel) 2020
Times Cited: 59







List of co-cited articles
380 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
David S Hong, Yoon-Koo Kang, Mitesh Borad, Jasgit Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew J Brenner, Keunchil Park, Jae-Lyun Lee, Tae-You Kim,[...]. Br J Cancer 2020
169
18


Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.
Muhammad S Beg, Andrew J Brenner, Jasgit Sachdev, Mitesh Borad, Yoon-Koo Kang, Jay Stoudemire, Susan Smith, Andreas G Bader, Sinil Kim, David S Hong. Invest New Drugs 2017
446
16

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
Nico van Zandwijk, Nick Pavlakis, Steven C Kao, Anthony Linton, Michael J Boyer, Stephen Clarke, Yennie Huynh, Agata Chrzanowska, Michael J Fulham, Dale L Bailey,[...]. Lancet Oncol 2017
291
15

Advances in oligonucleotide drug delivery.
Thomas C Roberts, Robert Langer, Matthew J A Wood. Nat Rev Drug Discov 2020
328
13

Metazoan MicroRNAs.
David P Bartel. Cell 2018
11

miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.
Carmen Elena Condrat, Dana Claudia Thompson, Madalina Gabriela Barbu, Oana Larisa Bugnar, Andreea Boboc, Dragos Cretoiu, Nicolae Suciu, Sanda Maria Cretoiu, Silviu Cristian Voinea. Cells 2020
223
11

Regulation of microRNA function in animals.
Luca F R Gebert, Ian J MacRae. Nat Rev Mol Cell Biol 2019
834
11


Silencing of microRNAs in vivo with 'antagomirs'.
Jan Krützfeldt, Nikolaus Rajewsky, Ravi Braich, Kallanthottathil G Rajeev, Thomas Tuschl, Muthiah Manoharan, Markus Stoffel. Nature 2005
10

Regulation of microRNA biogenesis.
Minju Ha, V Narry Kim. Nat Rev Mol Cell Biol 2014
10

Circulating MicroRNAs in Cancer: Potential and Challenge.
Mengying Cui, Hongdan Wang, Xiaoxiao Yao, Dan Zhang, Yingjun Xie, Ranji Cui, Xuewen Zhang. Front Genet 2019
132
10

The role of MicroRNAs in human cancer.
Yong Peng, Carlo M Croce. Signal Transduct Target Ther 2016
921
10

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.
Jacob O'Brien, Heyam Hayder, Yara Zayed, Chun Peng. Front Endocrinol (Lausanne) 2018
10

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Philip A Gregory, Andrew G Bert, Emily L Paterson, Simon C Barry, Anna Tsykin, Gelareh Farshid, Mathew A Vadas, Yeesim Khew-Goodall, Gregory J Goodall. Nat Cell Biol 2008
8


Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.
Anita G Seto, Xuan Beatty, Joshua M Lynch, Melanie Hermreck, Michael Tetzlaff, Madeleine Duvic, Aimee L Jackson. Br J Haematol 2018
115
8

MicroRNA biogenesis pathways in cancer.
Shuibin Lin, Richard I Gregory. Nat Rev Cancer 2015
8

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer.
Masayuki Hiraki, Junichi Nishimura, Hidekazu Takahashi, Xin Wu, Yusuke Takahashi, Masaaki Miyo, Naohiro Nishida, Mamoru Uemura, Taishi Hata, Ichiro Takemasa,[...]. Mol Ther Nucleic Acids 2015
55
9

The Potential for microRNA Therapeutics and Clinical Research.
Johora Hanna, Gazi S Hossain, Jannet Kocerha. Front Genet 2019
288
8

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

Most mammalian mRNAs are conserved targets of microRNAs.
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel. Genome Res 2009
6

Treatment of HCV infection by targeting microRNA.
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, Stefan Zeuzem, Maribel Rodriguez-Torres, Keyur Patel, Adriaan J van der Meer, Amy K Patick, Alice Chen, Yi Zhou,[...]. N Engl J Med 2013
6

How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market.
E Bonneau, B Neveu, E Kostantin, G J Tsongalis, V De Guire. EJIFCC 2019
118
6

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
Miranda Y Fong, Weiying Zhou, Liang Liu, Aileen Y Alontaga, Manasa Chandra, Jonathan Ashby, Amy Chow, Sean Timothy Francis O'Connor, Shasha Li, Andrew R Chin,[...]. Nat Cell Biol 2015
629
6

Progress in microRNA delivery.
Yu Zhang, Zaijie Wang, Richard A Gemeinhart. J Control Release 2013
355
6

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Li Ma, Julie Teruya-Feldstein, Robert A Weinberg. Nature 2007
6

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
6

Extracellular vesicles: biology and emerging therapeutic opportunities.
Samir EL Andaloussi, Imre Mäger, Xandra O Breakefield, Matthew J A Wood. Nat Rev Drug Discov 2013
6

A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells.
Akira Inoue, Tsunekazu Mizushima, Xin Wu, Daisuke Okuzaki, Nanami Kambara, Sho Ishikawa, Jiaqi Wang, Yamin Qian, Haruka Hirose, Yuhki Yokoyama,[...]. Mol Cancer Ther 2018
21
19

In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Yunching Chen, Dong-Yu Gao, Leaf Huang. Adv Drug Deliv Rev 2015
367
6

OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
Alexander A Svoronos, Donald M Engelman, Frank J Slack. Cancer Res 2016
407
6

Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.
Tomasz M Grzywa, Klaudia Klicka, Paweł K Włodarski. Cancers (Basel) 2020
10
40

Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo.
Eleni Anastasiadou, Anita G Seto, Xuan Beatty, Melanie Hermreck, Maud-Emmanuelle Gilles, Dina Stroopinsky, Lauren C Pinter-Brown, Linda Pestano, Cinzia Marchese, David Avigan,[...]. Clin Cancer Res 2021
28
14

microRNA-based diagnostic and therapeutic applications in cancer medicine.
Lorenzo F Sempere, Asfar S Azmi, Anna Moore. Wiley Interdiscip Rev RNA 2021
10
40

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
6

Improved targeting of miRNA with antisense oligonucleotides.
Scott Davis, Bridget Lollo, Susan Freier, Christine Esau. Nucleic Acids Res 2006
297
6

Gene regulation by long non-coding RNAs and its biological functions.
Luisa Statello, Chun-Jie Guo, Ling-Ling Chen, Maite Huarte. Nat Rev Mol Cell Biol 2021
506
6

The role and mechanisms of action of microRNAs in cancer drug resistance.
Wengong Si, Jiaying Shen, Huilin Zheng, Weimin Fan. Clin Epigenetics 2019
207
6

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, Chih-Chao Yang, Mitsuharu Ueda, Arnt V Kristen, Ivailo Tournev, Hartmut H Schmidt, Teresa Coelho, John L Berk,[...]. N Engl J Med 2018
6

Therapeutic siRNA: state of the art.
Bo Hu, Liping Zhong, Yuhua Weng, Ling Peng, Yuanyu Huang, Yongxiang Zhao, Xing-Jie Liang. Signal Transduct Target Ther 2020
171
6


miRBase: from microRNA sequences to function.
Ana Kozomara, Maria Birgaoanu, Sam Griffiths-Jones. Nucleic Acids Res 2019
5


LNA-mediated microRNA silencing in non-human primates.
Joacim Elmén, Morten Lindow, Sylvia Schütz, Matthew Lawrence, Andreas Petri, Susanna Obad, Marie Lindholm, Maj Hedtjärn, Henrik Frydenlund Hansen, Urs Berger,[...]. Nature 2008
5

In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.
Søren Ottosen, Todd B Parsley, Lu Yang, Karin Zeh, Leen-Jan van Doorn, Eva van der Veer, Anneke K Raney, Michael R Hodges, Amy K Patick. Antimicrob Agents Chemother 2015
118
5

Development of microRNA therapeutics is coming of age.
Eva van Rooij, Sakari Kauppinen. EMBO Mol Med 2014
393
5

Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.
Shin-ichiro Ohno, Masakatsu Takanashi, Katsuko Sudo, Shinobu Ueda, Akio Ishikawa, Nagahisa Matsuyama, Koji Fujita, Takayuki Mizutani, Tadaaki Ohgi, Takahiro Ochiya,[...]. Mol Ther 2013
905
5


RNA therapeutics: beyond RNA interference and antisense oligonucleotides.
Ryszard Kole, Adrian R Krainer, Sidney Altman. Nat Rev Drug Discov 2012
710
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.